NCT06579209View on ClinicalTrials.gov

NAD+ Oral Supplement Pilot Intervention in Adult Females

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
Cognitive ChangeInflammationNeurodegenerative Diseases
Interventions
DIETARY_SUPPLEMENT

Nicotinamide adenine dinucleotide

Participants will take a supplement for four weeks. The supplement will either be Nicotinamide adenine dinucleotide or a placebo

Trial Locations (2)

02881

RECRUITING

University of Rhode Island, Kingston

02860

RECRUITING

Independence Square, University of Rhode Island, Pawtucket

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of Rhode Island

OTHER